v3.26.1
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 2,803 $ 2,714 $ 5,556 $ 5,292
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of sales [1] $ (2,294) $ (2,213) $ (4,521) $ (4,312)
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Gross profit $ 509 $ 501 $ 1,035 $ 980
Selling, general and administrative expenses (138) (145) (299) (290)
Research, development and engineering expenses, net (122) (107) (242) (202)
Other income (expense), net [2] (56) (1) (65) 14
Operating income 192 247 429 502
Income from equity method investment 1 1 2 3
Interest income 2 2 5 4
Interest expense (26) (27) (53) (52)
Other non-operating items, net (15) (3) (27) (3)
Income before income taxes 154 221 356 453
Income tax expense (53) (53) (113) (118)
Net income [3] 101 168 242 335
Less: Net income attributable to non-controlling interest 0 0 1 1
Net income attributable to controlling interest $ 100 $ 167 $ 242 $ 334
Net earnings per share - basic $ 1.35 $ 2.17 $ 3.25 $ 4.32
Net earnings per share - diluted $ 1.35 $ 2.16 $ 3.24 $ 4.31
Weighted average number of shares outstanding, net of treasury shares (in millions) 74.1 77.1 74.3 77.3
Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions) 74.2 77.3 74.5 77.5
Cash dividend per share - declared [4] $ 0.87 $ 1.55 $ 1.74 $ 2.25
Cash dividend per share – paid $ 0.87 $ 0.7 $ 1.74 $ 1.4
[1] Including a gain on sale of property in China of $6 million in the first quarter of 2025. Including an impairment loss of $9 million related to the restructuring activities in Türkiye and a reversal of previously recognized supplier compensation of $13 million due to a court ruling in the second quarter of 2026.
[2] Including a cumulative translation gain of $11 million related to the sale of the Russian entity in the first quarter of 2025.
[3] For the three months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $0 million and a loss of $7 million, respectively. For the six months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $6 million and a loss of $14 million, respectively.
[4] In May 2025, the Company declared a dividend per share of $0.70 for the second quarter of 2025, and in June 2025, the Company declared a dividend per share of $0.85 for the third quarter of 2025.